Patients Delivering for patients and sites in 2025 As I look at 2025, and try to see what will happen in the world of clinical trials, it is important to see the progress we have made.
R&D Precision medicine, NGS, and the quantum leap in biomarkers In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
